Richard Mulligan - Net Worth and Insider Trading

Richard Mulligan Net Worth

The estimated net worth of Richard Mulligan is at least $9 Million dollars as of 2024-11-05. Richard Mulligan is the Director of Sana Biotechnology Inc and owns about 2,698,121 shares of Sana Biotechnology Inc (SANA) stock worth over $8 Million. Richard Mulligan is also the Director of Biogen Inc and owns about 2,020 shares of Biogen Inc (BIIB) stock worth over $355,278. Details can be seen in Richard Mulligan's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard Mulligan has not made any transactions after 2024-09-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Richard Mulligan

To

Richard Mulligan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Richard Mulligan owns 4 companies in total, including Biogen Inc (BIIB) , Enzon Pharmaceuticals Inc (ENZN) , and Bausch Health Companies Inc (BHC) among others .

Click here to see the complete history of Richard Mulligan’s form 4 insider trades.

Insider Ownership Summary of Richard Mulligan

Ticker Comapny Transaction Date Type of Owner
BIIB Biogen Inc 2013-05-28 director
ENZN Enzon Pharmaceuticals Inc 2010-07-01 director
BHC Bausch Health Companies Inc 2022-05-10 director
LIMIT LIMIT 2024-09-25 director & Head of SanaX

Richard Mulligan Latest Holdings Summary

Richard Mulligan currently owns a total of 2 stocks. Among these stocks, Richard Mulligan owns 2,698,121 shares of Sana Biotechnology Inc (SANA) as of September 25, 2024, with a value of $8 Million and a weighting of 95.96%. Richard Mulligan also owns 2,020 shares of Biogen Inc (BIIB) as of May 28, 2013, with a value of $355,278 and a weighting of 4.04%.

Latest Holdings of Richard Mulligan

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SANA Sana Biotechnology Inc 2024-09-25 2,698,121 3.13 8,431,628
BIIB Biogen Inc 2013-05-28 2,020 175.88 355,278

Holding Weightings of Richard Mulligan


Richard Mulligan Form 4 Trading Tracker

According to the SEC Form 4 filings, Richard Mulligan has made a total of 1 transactions in Sana Biotechnology Inc (SANA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Sana Biotechnology Inc is the sale of 300,000 shares on September 25, 2024, which brought Richard Mulligan around $1 Million.

According to the SEC Form 4 filings, Richard Mulligan has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 37,975 shares on May 28, 2013, which brought Richard Mulligan around $9 Million.

Insider Trading History of Richard Mulligan

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Richard Mulligan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Richard Mulligan Ownership Network

Ownership Network List of Richard Mulligan

No Data

Ownership Network Relation of Richard Mulligan

Insider Network Chart

Richard Mulligan Owned Company Details

What does Biogen Inc do?

Who are the key executives at Biogen Inc?

Richard Mulligan is the director of Biogen Inc. Other key executives at Biogen Inc include Head of Development Priya Singhal , Head of Research Jane Grogan , and EVP & Human Resources Ginger Gregory .

Biogen Inc (BIIB) Insider Trades Summary

Over the past 18 months, Richard Mulligan made no insider transaction in Biogen Inc (BIIB). Other recent insider transactions involving Biogen Inc (BIIB) include a net sale of 2,569 shares made by Priya Singhal , and a net purchase of 455 shares made by Eric K Rowinsky .

In summary, during the past 3 months, insiders sold 431 shares of Biogen Inc (BIIB) in total and bought 0 shares, with a net sale of 431 shares. During the past 18 months, 2,569 shares of Biogen Inc (BIIB) were sold and 455 shares were bought by its insiders, resulting in a net sale of 2,114 shares.

Biogen Inc (BIIB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Biogen Inc Insider Transactions

No Available Data

Richard Mulligan Mailing Address

Above is the net worth, insider trading, and ownership report for Richard Mulligan. You might contact Richard Mulligan via mailing address: C/o Icahn Capital Lp, 767 Fifth Avenue, Suite 4700, New York Ny 10153.